The status of a potential pathway out of the 37-day government shutdown remained foggy Thursday (Nov. 6) with House Republicans refusing to commit to a vote on a package that could extend the expiring enhanced ACA subsidies.
FREE TRIAL Receive 30 days of no-obligation access. SIGN UP
The Trump administration publicly announced its expected deal with Eli Lilly and Novo Nordisk to lower prices on their blockbuster GLP-1 drugs in exchange for Medicare and Medicaid coverage, with an Eli Lilly spokesperson confirming that Medicare coverage for weight-loss indications will be offered through a CMS pilot program that has yet to be announced.
The Trump administration’s planned Thursday announcement that Novo Nordisk and Eli Lilly will offer obesity drugs at $149 per month through TrumpRx is touted by an industry expert as a “brilliant” move by the president to achieve a significant price cut in the popular drugs by giving the drug makers an opportunity to significantly boost sales via a new Medicare coverage policy and on the TrumpRx platform.
The status of a potential pathway out of the 37-day government shutdown remained foggy Thursday (Nov. 6) with House Republicans refusing to commit to a vote on a package that could extend the expiring enhanced ACA subsidies.
Amgen has filed a second lawsuit against the Colorado Prescription Drug Affordability Board (PDAB) after the body voted in favor of implementing an upper payment limit (UPL) on Amgen’s immune system drug Enbrel in October, saying the action is “unconstitutional” and that it will decrease access to patients but doesn’t explain how.
FDA could resume its normal activities and have full-year appropriations finalized under a potential deal to reopen the government reportedly being floated by Senate appropriators.
The American Academy of Pediatrics and other organizations are amending their lawsuit against HHS Secretary Robert F. Kennedy Jr. to demand his hand-picked CDC vaccine advisors be dismissed, saying their selection based on political considerations with minimal vetting was illegal and the panel must be reconstituted with court supervision.
As applications close at midnight Wednesday (Nov. 5) for the GOP megabill’s rural health fund, CMS Administrator Mehmet Oz says all 50 states plan to apply -- and one state is touting its proposals to improve nutrition, strengthen the rural workforce and use telehealth to promote coordination of health care within rural communities.
CMS’ recently finalized Ambulatory Specialty Model (ASM), targeting specialists treating costly chronic conditions like heart failure and low back pain, will test the administration’s hypothesis that linking reimbursement to cost and quality outcomes can improve care and reduce spending.
HOT TOPICS
|
Senate health committee Chair Bill Cassidy (LA) on Tuesday (Nov. 4) introduced legislation that would extend privacy protections to health data collected by new technologies by “harmonizing” new regulatory action with existing health privacy protections that currently don’t cover smart watches and health apps. |
States, cities and nonprofit organizations are suing the Trump administration over its move to add new conditions to the Public Service Loan Forgiveness program, alleging the administration could deny loan forgiveness to employees at public hospitals, universities and charitable organizations that speak out against its policy priorities, creating recruiting problems for essential positions in health care and other fields. |
As the government shutdown wears on, FDA has provided an update on the activities the agency can continue, reminding sponsors some types of medical product submissions are still being accepted, including supplements to applications. |
Allegations that George Tidmarsh used his position as FDA’s top drug regulator to pursue a “vendetta” against a former business associate are likely to cast an additional pallor over an agency already facing skepticism from industry over a number of controversial drug decisions. |
Inside Health Policy is a subscription-fee-based daily digital news service from Inside Washington Publishers.
Economical site license packages are available to fit any size organization, from a few people at one location to company-wide access. For more information on how you can get greater access to Inside Health Policy for your office, contact Online Customer Service at 703-416-8505 or healthpolicy@iwpnews.com.
© 2002-2025. Inside Washington Publishers | Contact Us